Humana/$HUM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Humana
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Ticker
$HUM
Sector
Primary listing
NYSE
Industry
Health Care Providers and Services
Headquarters
Employees
65,680
ISIN
US4448591028
Website
Humana Metrics
BasicAdvanced
$27B
15.79
$14.16
0.43
$3.54
1.58%
Price and volume
Market cap
$27B
Beta
0.43
52-week high
$406.46
52-week low
$212.45
Average daily volume
1.6M
Dividend rate
$3.54
Financial strength
Current ratio
1.908
Quick ratio
1.474
Long term debt to equity
71.76
Total debt to equity
77.075
Dividend payout ratio (TTM)
25.15%
Interest coverage (TTM)
5.77%
Profitability
EBITDA (TTM)
4,097
Gross margin (TTM)
15.12%
Net profit margin (TTM)
1.42%
Operating margin (TTM)
3.17%
Effective tax rate (TTM)
24.86%
Revenue per employee (TTM)
$1,830,000
Management effectiveness
Return on assets (TTM)
4.72%
Return on equity (TTM)
10.10%
Valuation
Price to earnings (TTM)
15.787
Price to revenue (TTM)
0.224
Price to book
1.52
Price to tangible book (TTM)
4.03
Price to free cash flow (TTM)
11.313
Free cash flow yield (TTM)
8.84%
Free cash flow per share (TTM)
1,976.05%
Dividend yield (TTM)
1.58%
Forward dividend yield
1.58%
Growth
Revenue change (TTM)
10.09%
Earnings per share change (TTM)
-12.24%
3-year revenue growth (CAGR)
11.19%
10-year revenue growth (CAGR)
9.04%
3-year earnings per share growth (CAGR)
-15.60%
10-year earnings per share growth (CAGR)
6.13%
3-year dividend per share growth (CAGR)
7.03%
10-year dividend per share growth (CAGR)
12.20%
What the Analysts think about Humana
Analyst ratings (Buy, Hold, Sell) for Humana stock.
Bulls say / Bears say
Humana's recent expansion of climate targets with new financial emissions goals demonstrates a commitment to sustainability, potentially enhancing its reputation and attracting environmentally conscious investors. (Investing.com)
The company's initiative to simplify prior approval requirements aligns with industry trends towards improving patient experience, which could lead to increased customer satisfaction and retention. (Reuters)
Humana's involvement in community engagement activities, such as the National Mall of Pickleball, showcases its dedication to promoting active lifestyles, potentially strengthening brand loyalty among consumers. (Investing.com)
Humana's stock experienced a significant drop of 10.72% following UnitedHealth Group's slashed 2025 outlook, indicating potential sector-wide challenges that could impact Humana's financial performance. (Ainvest)
The departure of CFO Susan Diamond after an 18-year tenure raises concerns about potential disruptions in financial strategy and leadership stability within the company. (Nasdaq)
Humana's stock plunged over 10% due to a dismal 2024 forecast, citing soaring medical costs as a significant challenge, which may continue to pressure the company's profitability. (NBC Chicago)
Data summarised monthly by Lightyear AI. Last updated on 9 Jul 2025.
Humana Financial Performance
Revenues and expenses
Humana Earnings Performance
Company profitability
Humana News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jul25
Humana
Dividend·Payment
$0.885Per share
FAQs
What’s the current market cap for Humana stock?
Humana (HUM) has a market cap of $27B as of July 18, 2025.
What is the P/E ratio for Humana stock?
The price to earnings (P/E) ratio for Humana (HUM) stock is 15.79 as of July 18, 2025.
Does Humana stock pay dividends?
Yes, the Humana (HUM) stock pays dividends to shareholders. As of July 18, 2025, the dividend rate is $3.54 and the yield is 1.58%. Humana has a payout ratio of 25.15% on a trailing twelve-month basis.
When is the next Humana dividend payment date?
The next Humana (HUM) dividend payment is scheduled for July 25, 2025.
What is the beta indicator for Humana?
Humana (HUM) has a beta rating of 0.43. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.